Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Stapleton, David I ^a   Lau, Xianzhong ^a   Flores, Marcelo ^a   Trieu, Jennifer ^a   Gehrig, Stefan M ^a   Chee, Annabel ^a   Naim, Timur ^a   Lynch, Gordon S ^a   Koopman, René ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 ALPHA GLUCAN BRANCHING ENZYME; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DYSTROPHIN; GLYCOGEN PHOSPHORYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; ENZYME REGULATION; GLUCOSE INTOLERANCE; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; GLYCOGEN MUSCLE LEVEL; GLYCOGEN SYNTHESIS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; C57BL MOUSE; DISEASE MODEL; LIVER; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SKELETAL MUSCLE; TRANSGENIC MOUSE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; DYSTROPHIN; GLUCOSE INTOLERANCE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE, SKELETAL; PHENOTYPE;

EID: 84898767509     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091514     Document Type: Article

References (37)

1. Freidenberg GR, Olefsky JM (1985) Dissociation of insulin resistance and decreased insulin receptor binding in Duchenne muscular dystrophy. The Journal of clinical endocrinology and metabolism 60: 320-327. (Pubitemid 15129579)
2. Wineinger MA, Abresch RT, Walsh SA, Carter GT (1998) Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. American journal of physical medicine & rehabilitation/Association of Academic Physiatrists 77: 20-27.
3. MacLennan PA, McArdle A, Edwards RH (1991) Acute effects of phorbol esters on the protein-synthetic rate and carbohydrate metabolism of normal and mdx mouse muscles. The Biochemical journal 275 (Pt 2): 477-483.
4. Ellis DA (1980) Intermediary metabolism of muscle in Duchenne muscular dystrophy. British medical bulletin 36: 165-171.
5. Frosig C, Richter EA (2009) Improved insulin sensitivity after exercise: focus on insulin signaling. Obesity 17 Suppl 3: S15-20.
6. Caudwell FB, Cohen P (1980) Purification and subunit structure of glycogen-branching enzyme from rabbit skeletal muscle. Eur J Biochem 109: 391-394.
7. Gibson WB, Illingsworth B, Brown DH (1971) Studies of glycogen branching enzyme. Preparation and properties of -1,4-glucan- -1,4-glucan 6-glycosyltransferase and its action on the characteristic polysaccharide of the liver of children with Type IV glycogen storage disease. Biochemistry 10: 4253-4262.
8. Ortenblad N, Nielsen J, Saltin B, Holmberg HC (2011) Role of glycogen availability in sarcoplasmic reticulum Ca2+ kinetics in human skeletal muscle. The Journal of Physiology 589: 711-725.
9. Gehrig SM, Koopman R, Naim T, Tjoakarfa C, Lynch GS (2010) Making Fast-Twitch Dystrophic Muscles Bigger Protects Them from Contraction Injury and Attenuates the Dystrophic Pathology. The American Journal of Pathology 176: 29-33.
10. Ham DJ, Murphy KT, Chee A, Lynch GS, Koopman R (2013) Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia. Clinical Nutrition.
11. Ryu JH, Drain J, Kim JH, McGee S, Gray-Weale A, et al. (2009) Comparative structural analyses of purified glycogen particles from rat liver, human skeletal muscle and commercial preparations. International journal of biological macromolecules 45: 478-482.
12. Thomas JA, Schlender KK, Larner J (1968) A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Analytical Biochemistry 25: 486-499.
13. Zhang T, Wang S, Lin Y, Xu W, Ye D, et al. (2012) Acetylation Negatively Regulates Glycogen Phosphorylase by Recruiting Protein Phosphatase 1. Cell Metabolism 15: 75-87.
14. Brown BI, Brown DH (1966) Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis. Proceedings of the National Academy of Sciences of the United States of America 56: 725-729.
15. Koopman R, Manders RF, Jonkers RM, Hul GJ, Kuipers H, et al. (2006) Intramyocellular lipid and glycogen content are reduced following resistance exercise in untrained healthy males. European Journal of Applied Physiology 96: 525-534.
16. Stapleton D, Nelson C, Parsawar K, McClain D, Gilbert-Wilson R, et al. (2010) Analysis of hepatic glycogen-associated proteins. Proteomics 10: 2320-2329.
17. Watkins SC, Cullen MJ (1987) A qualitative and quantitative study of the ultrastructure of regenerating muscle fibres in Duchenne muscular dystrophy and polymyositis. Journal of the neurological sciences 82: 181-192. (Pubitemid 18001999)
18. Sharma U, Atri S, Sharma MC, Sarkar C, Jagannathan NR (2003) Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magnetic resonance imaging 21: 145-153. (Pubitemid 36418733)
19. McArdle A, Edwards RHT, Jackson MJ (1995) How does dystrophin deficiency lead to muscle degeneration - evidence from the mdx mouse Neuromuscular Disorders 5: 445-456.
20. Roach PJ, Depaoli'ÄëRoach AA, Hurley TD, Tagliabracci VS (2012) Glycogen and its metabolism: some new developments and old themes. Biochem J 441: 763-787.
21. Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS (2012) Glycogen and its metabolism: some new developments and old themes. The Biochemical journal 441: 763-787.
22. Jiang S, Wells CD, Roach PJ (2011) Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: Identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1. Biochem Biophys Res Commun 413: 420-425.
23. Sullivan MA, Li J, Li C, Vilaplana F, Stapleton D, et al. (2011) Molecular structural differences between type-2-diabetic and healthy glycogen. Biomacromolecules 12: 1983-1986.
24. Ros S, Garcia-Rocha M, Calbo J, Guinovart JJ (2011) Restoration of hepatic glycogen deposition reduces hyperglycaemia, hyperphagia and gluconeogenic enzymes in a streptozotocin-induced model of diabetes in rats. Diabetologia 54: 2639-2648.
25. Lau X, Zhang Y, Kelly DJ, Stapleton DI (2013) Attenuation of Armanni-Ebstein lesions in a rat model of diabetes by a new anti-fibrotic, anti-inflammatory agent, FT011. Diabetologia 56: 675-679.
26. Koubi H, Duchamp C, Geloen A, Freminet A, Minaire Y (1991) Resistance of hepatic glycogen to depletion in obese Zucker rats. Canadian journal of physiology and pharmacology 69: 841-845.
27. Shearer J, Ross KD, Hughey CC, Johnsen VL, Hittel DS, et al. (2011) Exercise training does not correct abnormal cardiac glycogen accumulation in the db/db mouse model of type 2 diabetes. American journal of physiology Endocrinology and metabolism 301: E31-39.
28. Bao Y, Kishnani P, Wu J-Y, Chen Y-T (1996) Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. Journal of Clinical Investigation 97: 941.
29. Jiang S, Heller B, Tagliabracci VS, Zhai L, Irimia JM, et al. (2010) Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism. J Biol Chem 285: 34960-34971.
30. van Maanen M-H, Fournier PA, Palmer TN, Abraham LJ (1999) Characterization of mouse glycogenin-1 cDNA and promoter region. Biochim Biophys Acta 1447: 284-290. (Pubitemid 29495003)
31. Srivastava U, Sebag M, Thakur M (1981) Biochemical changes in progressive muscular dystrophy. XI. Cyclic nucleotides in the skeletal and cardiac muscle of normal and dystrophic mice. Canadian journal of physiology and pharmacology 59: 329-334. (Pubitemid 11030468)
32. Reynolds JG, McCalmon SA, Donaghey JA, Naya FJ (2008) Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy. Journal of Biological Chemistry 283: 8070-8074.
33. Roder IV, Lissandron V, Martin J, Petersen Y, Di Benedetto G, et al. (2009) PKA microdomain organisation and cAMP handling in healthy and dystrophic muscle in vivo. Cellular signalling 21: 819-826.
34. Freidenberg GR, Freidenberg JM, Olefsky (1985) Dissociation of Insulin Resistance and Decreased Insulin Receptor Binding in Duchenne Muscular Dystrophy. The Journal of clinical endocrinology and metabolism 60: 320-327. (Pubitemid 15129579)
35. Matsumura T, Iwahashi H, Funahashi T, Takahashi MP, Saito T, et al. (2009) A cross-sectional study for glucose intolerance of myotonic dystrophy. Journal of the neurological sciences 276: 60-65.
36. Rufo A, Del Fattore A, Capulli M, Carvello F, De Pasquale L, et al. (2011) Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. Journal of Bone and Mineral Research 26: 1891-1903.
37. Lienenlüke B, Christ B (2007) Impact of interleukin-6 on the glucose metabolic capacity in rat liver. Histochemistry and cell biology 128: 371-377. (Pubitemid 47415783)